Q1 2024
Released May 9, 2024, after the close
10-Q filed May 9, 2024, 39 days after period end · 0001493152-24-018483
Q1 2024 · 10-Q
Revenue$3.52M$3.52M −4.7% vs Q1 2023+8.2% vs Q4 2023
Net Income-$169.00K-$169.00K N/M vs Q1 2023N/M vs Q4 2023
EPS Diluted-$0.02-$0.02 N/M vs Q1 2023no prior Q4 2023 on file
Gross Profit$2,187,000+3.6%
Operating Income-$200,000N/M
Operating Cash Flow-$672,000N/M
Margins · derived
Gross margin62.1%+5.0 pt vs Q1 2023
Operating margin-5.7%+2.6 pt vs Q1 2023
Net margin-4.8%+3.5 pt vs Q1 2023
What the release said
The release
Same quarter
| Metric | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|
| Revenue | $3.52M | $3.70M | $2.16M | $2.74M |
| Net Income | -$169.00K | -$306.00K | -$1.97M | -$537.00K |
| EPS Diluted | -$0.02 | -$0.03 | — | -$0.06 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nephros Inc · CIK 1196298 · Engraved from SEC EDGAR